Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,232,645
-$616,475 QoQ
Shares Held
8,927
-25.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,035
of 3,139 holders
Holding Since
Sep 2021
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Sep 30, 2021CallValue
$16,629,230
CallShares
78,200
PutValue
$18,628,140
PutShares
87,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IMC-Chicago, LLC holds $56,648,218 across 9 Drug Manufacturers - General names. AMGN ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,449 | $30,524,296 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
128,157 | $7,384,406 | |
| 3 | BIIB |
Biogen Inc.
|
20,649 | $4,461,422 | |
| 4 | PFE |
Pfizer Inc
|
173,689 | $4,182,431 | |
| 5 | AMGN |
Amgen Inc
This page
|
8,927 | $3,232,645 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,216 | $2,933,109 | |
| 7 | NVS |
Novartis AG
|
9,740 | $1,526,452 | |
| 8 | AZN |
Astrazeneca PLC
|
7,754 | $1,470,313 |
All Filings in AMGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,232,645 | 8,927 | Shares | Sole | 2026-08-06 | |
| 2024-09-30 | $3,849,120 | 11,946 | Shares | Sole | 2024-10-25 | |
| 2021-09-30 | $18,628,140 | 87,600 | Put | Sole | 2021-11-05 | |
| 2021-09-30 | $16,629,230 | 78,200 | Call | Sole | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||